Arcus Biosciences (RCUS) Change in Cash (2017 - 2026)
Arcus Biosciences' quarterly Change in Cash came in at -$21.0 million in Q1 2026, down 150.0% year-on-year from $42.0 million in Q1 2025, and down 31.25% quarter-over-quarter from -$16.0 million in Q4 2025.
Arcus Biosciences has reported Change in Cash for 10 years, with the latest figure at -$21.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 150.0% year-over-year to -$21.0 million; the trailing twelve-month figure through Mar 2026 stood at $9.0 million (up 28.57% YoY), and the FY2025 full-year result was $72.0 million, up 213.04% from the prior year.
- Change in Cash for Q1 2026 stood at -$21.0 million, down from -$16.0 million in the prior quarter.
- The five-year high for Change in Cash was $401.0 million in Q1 2022, with the low at -$276.0 million in Q2 2022.
- Average Change in Cash over 5 years is $3.1 million, with a median of -$12.0 million recorded in 2022.
- Year-over-year, Change in Cash tumbled 375.0% in 2023 and surged 293.1% in 2025.
- Tracing RCUS's Change in Cash over 5 years: stood at -$12.0 million in 2022, then plunged by 375.0% to -$57.0 million in 2023, then grew by 10.53% to -$51.0 million in 2024, then jumped by 68.63% to -$16.0 million in 2025, then plunged by 31.25% to -$21.0 million in 2026.
- The last three Change in Cash figures came in at -$21.0 million (Q1 2026), -$16.0 million (Q4 2025), and -$10.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - | -21.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.00 Mn |
| Dec 31, 2025 | -16.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | 56.00 Mn |
| Mar 31, 2025 | 42.00 Mn |
| Dec 31, 2024 | -51.00 Mn |
| Sep 30, 2024 | 45.00 Mn |
| Jun 30, 2024 | -29.00 Mn |
| Mar 31, 2024 | 58.00 Mn |
| Dec 31, 2023 | -57.00 Mn |
| Sep 30, 2023 | -46.00 Mn |
| Jun 30, 2023 | -8.00 Mn |
| Mar 31, 2023 | 32.00 Mn |
| Dec 31, 2022 | -12.00 Mn |
| Sep 30, 2022 | -55.00 Mn |
| Jun 30, 2022 | -276.00 Mn |
| Mar 31, 2022 | 401.00 Mn |
| Dec 31, 2021 | -31.82 Mn |
| Sep 30, 2021 | -141.05 Mn |
| Jun 30, 2021 | -68.76 Mn |
| Mar 31, 2021 | 218.63 Mn |
| Dec 31, 2020 | -47.91 Mn |
| Sep 30, 2020 | -63.34 Mn |
| Jun 30, 2020 | 217.86 Mn |
| Mar 31, 2020 | 9.39 Mn |
| Dec 31, 2019 | -21.06 Mn |
| Sep 30, 2019 | 2.92 Mn |
| Jun 30, 2019 | 7.57 Mn |
| Mar 31, 2019 | -2.57 Mn |
| Dec 31, 2018 | -3.83 Mn |
| Sep 30, 2018 | -95.11 Mn |
| Jun 30, 2018 | -28.12 Mn |
| Mar 31, 2018 | 99.69 Mn |
| Dec 31, 2017 | 80.12 Mn |
| Sep 30, 2017 | -11.31 Mn |
| Jun 30, 2017 | -9.48 Mn |
| Mar 31, 2017 | -26.06 Mn |